Belite Bio Inc.

10/01/2022 | Press release | Distributed by Public on 10/01/2022 17:36

Belite Bio Presented 12-Month Interim Results of LBS-008 Phase 1b/2 Study in Adolescent Stargardt Disease at AAO Annual Meeting 2022